Table 1 Baseline characteristics of the total study population (n = 482)
Age | 70 (67.5, 72.6) |
Metabolic syndrome | 182 (38) |
Number of criteria fulfilled | |
0 | 19 (4) |
1 | 113 (23) |
2 | 168 (35) |
3 | 111 (23) |
4 | 60 (12) |
5 | 11 (2) |
Body mass index (kg/m2) | 26.5 (24.3, 28.6) |
Waist circumference (cm) | 98 (92, 103) |
Systolic blood pressure (mmHg) | 148 (135, 160) |
Diastolic blood pressure (mmHg) | 84 (91, 77) |
Previous hypertension | 150 (31) |
Previous diabetes mellitus | 79 (16) |
Previous myocardial infarction | 89 (18) |
Current smokers | 160 (33) |
Aspirin | 131 (27) |
Statins | 135 (28) |
Antidiabetics | 21 (4) |
HbA1c (%) | 5.6 (5.3, 5.9) |
Insulin (pmol/L) | 118 (94, 154) |
HOMA (units) | 4.2 (3.3, 5.7) |
CRP (mg/L) | 3.27 (1.7, 5.8) |
IL-6 (pg/mL) | 1.53 (1.00, 2.45) |
TNFα (pg/mL) | 1.10 (0.78, 1.89) |
IL-18 (pg/mL) | 274 (212, 350) |
LBP (µg/mL) | 12.9 (10.4, 15.2) |
sCD14 (ng/mL) | 1293 (1052, 1515) |